93 related articles for article (PubMed ID: 557069)
1. Antibodies against human lymphokines: I. Methods for induction of antibodies capable of neutralizing stable (alpha) and unstable (beta) lymphotoxins released in vitro by activated human lymphocytes.
Lewis JE; Carmack CE; Yamamoto R; Granger GA
J Immunol Methods; 1977; 14(2):163-76. PubMed ID: 557069
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human lymphocyte-mediated mitogen-induced cytotoxicity of murine L-929 cells by heterologous anti-human lymphotoxin antisera in vitro.
Hiserodt JC; Granger GA
J Immunol; 1977 Aug; 119(2):374-80. PubMed ID: 301888
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic activity of lymphocytes. VI. Heterogeneity of cytotoxins in supernatants of mitogen-activated lymphocytes.
Walker SM; Lee SC; Lucas ZJ
J Immunol; 1976 Mar; 116(3):807-15. PubMed ID: 1082895
[TBL] [Abstract][Full Text] [Related]
4. The human LT serum. X. The initial form released by T-enriched lymphocytes is 150,000 m.w., associated with small nonlytic components, and can dissociate into the smaller alpha, beta, and gamma m.w. classes.
Harris PC; Yamamoto RS; Crane J; Granger GA
J Immunol; 1981 Jun; 126(6):2165-70. PubMed ID: 6164723
[TBL] [Abstract][Full Text] [Related]
5. A physicochemical and immunologic comparison of the cell growth inhibitory activity of human lymphotoxins and interferons in vitro.
Ware CF; Granger GA
J Immunol; 1979 May; 122(5):1763-70. PubMed ID: 312850
[TBL] [Abstract][Full Text] [Related]
6. Relationship of CIF, LT, and PIF released in vitro by activated human lymphocytes. II. A further functional comparison of LT and PIF activities on HeLa and L-929 target cells.
Jeffes EW; Granger GA
J Immunol; 1976 Jul; 117(1):174-9. PubMed ID: 1084364
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human NK-induced cell lysis and soluble cell-lytic molecules with anti-human LT antisera and various saccharides.
Weitzen ML; Innins E; Yamamoto RS; Granger GA
Cell Immunol; 1983 Apr; 77(1):42-51. PubMed ID: 6601529
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of lymphocyte-mediated cytotoxicity. I. The effects of anti-human lymphotoxin antisera on the cytolysis of allogeneic B cell lines by MLC-sensitized human lymphocytes in vitro.
Ware CF; Granger GA
J Immunol; 1981 May; 126(5):1919-26. PubMed ID: 6452481
[TBL] [Abstract][Full Text] [Related]
9. Human T cell hybridomas producing cytotoxic lymphokines: induction of lymphotoxin release and killer cell activity by anti-CD3 monoclonal antibody or lectins and phorbol ester.
Ware CF; Green LM; Reade J; Stern ML; Berger AE
Lymphokine Res; 1986; 5(4):313-24. PubMed ID: 2878123
[TBL] [Abstract][Full Text] [Related]
10. In vitro lymphocyte cytotoxicity. II. Unstable lymphotoxins (beta-LT) secreted and inactivated by mitogen-stimulated human lymphocytes.
Hiserodt JC; Granger GA
Cell Immunol; 1976 Oct; 26(2):211-6. PubMed ID: 1086143
[No Abstract] [Full Text] [Related]
11. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL-produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha-lymphotoxin.
Green LM; Reade JL; Ware CF; Devlin PE; Liang CM; Devlin JJ
J Immunol; 1986 Dec; 137(11):3488-93. PubMed ID: 2431035
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors.
Sheehan KC; Ruddle NH; Schreiber RD
J Immunol; 1989 Jun; 142(11):3884-93. PubMed ID: 2469726
[TBL] [Abstract][Full Text] [Related]
13. I. Evidence that lymphotoxin activity involves both cytotoxic and stimulating factors.
Ryzewska AG; Darbrowska BK
Immunology; 1976 Nov; 31(5):677-87. PubMed ID: 136420
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. I. Cytotoxins produced by antigen-specific and natural killer-like CTL are dissimilar to classical lymphotoxins.
Green LM; Stern ML; Haviland DL; Mills BJ; Ware CF
J Immunol; 1985 Dec; 135(6):4034-43. PubMed ID: 2415596
[TBL] [Abstract][Full Text] [Related]
15. Anti-lymphokine antibody. II. Specificity of biological activity.
Kuratsuji T; Yoshida T; Cohen S
J Immunol; 1976 Nov; 117(5 Pt.2):1985-91. PubMed ID: 792334
[TBL] [Abstract][Full Text] [Related]
16. The role of lymphotoxin in target cell destruction induced by mitogen-activated human lymphocytes in vitro. II. The correlation of temperature and trypsin-sensitive phases of lymphotoxin-induced and lymphocyte-mediated cytotoxicity.
Kramer SL; Granger GA
J Immunol; 1976 Feb; 116(2):562-7. PubMed ID: 1082459
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to guinea pig lymphokines. II. Suppression of delayed hypersensitivity reactions by a "second generation" goat antibody against guinea pig lymphokines.
Geczy CL; Geczy AF; De Weck AL
J Immunol; 1976 Jul; 117(1):66-72. PubMed ID: 1084371
[TBL] [Abstract][Full Text] [Related]
18. In vitro immunization. Effect of growth and differentiation factors on antigen-specific B cell activation and production of monoclonal antibodies to autologous antigens and weak immunogens.
Borrebaeck CA; Möller SA
J Immunol; 1986 May; 136(10):3710-5. PubMed ID: 3486221
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
[TBL] [Abstract][Full Text] [Related]
20. Studies on lymphokines: the production of antibody to guinea pig lymphotoxin and its use to distinguish lymphotoxin from migration inhibitory factor and mitogenic factor.
Gately MK; Gately CL; Henney CS; Mayer MM
J Immunol; 1975 Sep; 115(3):817-26. PubMed ID: 1097529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
